Similar Articles

Incorporating patient preferences into osteoarthritis treatment

Yeşim Gökçe Kutsal, Sibel Eyigör, Sevilay Karahan, Rezzan Günaydın, Jale İrdesel, Merih Sarıdoğan, Pınar Borman, Aylin Sarı, Kutay Ordu Gökkaya, Vildan Binay Safer

DOI: 10.46497/ArchRheumatol.2022.8291

Issue: Volume 36 - Issue 4 - December 2021
1758 2204

Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study

Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz

DOI: 10.46497/ArchRheumatol.2022.8669

Issue: Volume 37 - Issue 1 - March 2022
2514 1699

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats

Dawei Lv, Xiaodong Zhao

DOI: 10.46497/ArchRheumatol.2023.9240

Issue: Volume 38 - Issue 1 - March 2023
1773 1582

Unmet needs in psoriatic arthritis, a narrative review

Clementina Lopez-Medina, Umut Kalyoncu, Laure Gossec

DOI: 10.46497/ArchRheumatol.2024.10710

Issue: Volume 39 - Issue 2 - June 2024
3119 1538

New and future perspectives in Behçet's syndrome

Bercemhan Sulu, Gulen Hatemi

DOI: 10.46497/ArchRheumatol.2024.11049

Issue: Volume 39 - Issue 4 - December 2024
1367 1217

Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis

Elif Altunel Kılınç, Bengisu Ece Duman, Süleyman Özbek

DOI: 10.46497/ArchRheumatol.2025.10989

Issue: Volume 40 - Issue 1 - March 2025
103 108